Metalloestrogens
Metalloestrogens are metals that activate the estrogen receptor in the absence of estradiol.
-
Karen Pendergrass
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease—four years before the first published case study.
Microbiome Signatures identifies and validates condition-specific microbiome shifts and interventions to accelerate clinical translation. Our multidisciplinary team supports clinicians, researchers, and innovators in turning microbiome science into actionable medicine.
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease—four years before the first published case study.
Overview
Metalloestrogens are a class of metal ions that can mimic estrogen, binding to estrogen receptors (ER) and influencing estrogenic pathways in the body. These metals disrupt normal hormonal functions by triggering or amplifying estrogenic responses, making them relevant to diseases that are hormonally driven, such as breast cancer and endometriosis. The key metalloestrogens include aluminum (Al), arsenic (As), barium (Ba), cadmium (Cd), chromium (Cr), cobalt (Co), copper (Cu), lead (Pb), mercury (Hg), nickel (Ni), selenium (Se), and tin (Sn). These metals can interfere with estrogen receptor (ER) signaling by either directly binding to the ER or by affecting estrogen synthesis, metabolism, and elimination. Their role as “xenoestrogens” places them within the broader category of endocrine-disrupting chemicals (EDCs). [1]
Metalloestrogens and the Microbiome
The gut microbiome plays a crucial role in hormone regulation, including estrogen metabolism. Certain gut bacteria are known to bind or metabolize metals, which can modulate the availability and activity of metalloestrogens. However, chronic exposure to these metals may lead to shifts in microbial diversity, reducing beneficial bacteria that help detoxify and excrete excess estrogen and metalloestrogens from the body. Disruption of the microbiome by metalloestrogens can lead to imbalances in estrogen levels by altering the activity of bacterial enzymes such as β-glucuronidase, which reactivates estrogen from its conjugated form in the gut. This microbial dysbiosis, coupled with metal-induced toxicity, can have a dual impact on the hormonal balance, compounding the effects of metalloestrogens in conditions like breast cancer or endometriosis.
Mechanism of Action
Metalloestrogens bind to estrogen receptors (ERα and ERβ) on cells, triggering cellular responses similar to natural estrogens. Their structural mimicry allows them to engage in estrogen-mediated transcription processes, potentially altering gene expression. They can also interfere with the regulation of the cell cycle, promoting proliferation and preventing apoptosis, both of which are critical in the pathogenesis of hormone-related cancers. Certain metalloestrogens also cause oxidative stress by producing reactive oxygen species (ROS), further contributing to the disruption of hormonal balance and leading to cellular damage that can drive carcinogenesis or the progression of other diseases like endometriosis.
Metalloestrogens in Human Health and Disease
Metalloestrogens, including cadmium, nickel, and aluminum, have been associated with various hormone-related conditions due to their ability to mimic estrogen. In breast cancer, these metals have been detected in breast tissue and can stimulate the growth of estrogen receptor (ER)-positive cancer cells, raising concerns about their chronic exposure. Similarly, in endometriosis, a condition driven by estrogen where uterine-like tissue grows outside the uterus, metalloestrogens cadmium, nickel, and lead have been implicated in the etiology of the condition. [2] Additionally, these metals act as co-factors for enzymes that contribute to the virulence of pathogenic microbes linked to endometriosis. Furthermore, reproductive disorders such as fertility issues, menstrual irregularities, and early puberty have been connected to exposure to metals like cadmium and lead, which disrupt normal estrogenic pathways, further emphasizing their role in hormonal dysregulation.
Avoiding/Reducing Exposure
Avoiding and reducing exposure to metalloestrogens is essential due to their potential to mimic estrogen and disrupt hormonal pathways. Effective strategies include chelation and adsorption therapies, dietary modifications, and minimizing environmental and occupational exposure to harmful metals. By implementing these measures, individuals can reduce the burden of metalloestrogens on their endocrine system, thereby mitigating their associated health risks.
What interventions might be helpful for reducing exposure?
Adsorption Therapy: While further research to confirm its clinical efficacy in removing metalloestrogens is required, clinoptilolite zeolite has demonstrated significant potential due to its adsorptive properties. By facilitating metal ion detoxification, clinoptilolite offers a novel approach to reducing the estrogenic burden of inorganic sources in the body. Its porous structure provides an extensive surface area capable of trapping and immobilizing metal ions, preventing their interaction with biological systems such as estrogen receptors. This reduces their potential to disrupt endocrine function. Additionally, clinoptilolite’s high cation-exchange capacity allows it to replace naturally occurring ions, like sodium, potassium, and calcium, with toxic metal ions such as cadmium, lead, and nickel—key metalloestrogens—further enhancing its detoxifying action.
Chelation Therapy: Chelation therapy involves the administration of agents that bind to metals and facilitate their excretion. This approach has been explored to reduce the body burden of metalloestrogens, particularly in cases of metal toxicity. Dimethylglyoxime (DMG) has been widely used in chelation studies, particularly in the context of binding and detecting nickel. In reference to metalloestrogens, DMG chelation studies provide valuable insights, especially regarding metals like nickel that act as metalloestrogens. DMG is a reagent that forms a stable, water-insoluble complex with nickel, making it a useful tool for detecting and removing nickel from biological systems.
Dietary modifications: Dietary modifications play a critical role in reducing exposure to metalloestrogens and enhancing the body’s detoxification pathways. A high-fiber diet is particularly beneficial, as fiber supports gut health and aids in the excretion of estrogens and xenoestrogens, including metalloestrogens, by binding to them in the gut and reducing reabsorption through enterohepatic circulation. Incorporating antioxidant-rich foods also provides support to the body’s detoxification mechanisms. For individuals with nickel-mediated diseases, such as endometriosis or irritable bowel syndrome (IBS), adopting a low-nickel diet is another effective intervention.
FAQs
What are metalloestrogens and how do they affect human health?
Metalloestrogens are metal ions, such as cadmium, nickel, arsenic, and aluminum, that mimic the hormone estrogen by binding to estrogen receptors in the body. They disrupt normal hormonal signaling and can amplify estrogenic responses, which are implicated in the development of hormonally driven conditions.
The most well-researched associations are with breast cancer, where they stimulate estrogen receptor-positive cell growth. They are also associated with endometriosis, reproductive health disorders (e.g., infertility), gestational diabetes mellitus (GDM), and potentially prostate cancer and cardiovascular diseases. Their role in disrupting hormonal pathways makes them relevant in a broad range of conditions.
Research Feed
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Proin ut laoreet tortor. Donec euismod fermentum pharetra. Nullam at tristique enim. In sit amet molestie
This systematic review and meta-analysis identified arsenic, antimony, and copper as metalloestrogens associated with an increased risk of gestational diabetes mellitus (GDM). The findings highlight the significance of environmental metal exposure in pregnancy, underscoring the need for public health policies to mitigate these risks and further research into the mechanisms linking metalloestrogens to GDM.
What Was Reviewed?
The systematic review and meta-analysis examined the relationship between exposure to metalloestrogens—specifically arsenic (As), antimony (Sb), chromium (Cr), cadmium (Cd), copper (Cu), selenium (Se), and mercury (Hg)—and the risk of developing gestational diabetes mellitus (GDM). This review aimed to aggregate findings from observational studies to better understand how these metals, which have estrogenic properties, impact the development of GDM. A comprehensive search of PubMed, Web of Science, and Embase databases was conducted to collect relevant studies up until December 2023.Who Was Reviewed?
The meta-analysis included a total of 33 observational studies, which involved 141,175 subjects, comprising 9,450 cases of GDM and 131,725 controls. The review covered a wide geographic distribution, with studies conducted in multiple countries and varying methodologies for exposure assessment. Biological specimens such as blood, urine, and other tissues were analyzed to measure levels of metalloestrogens in pregnant women and correlate them with the occurrence of GDM.What Were the Most Important Findings of This Review?
The meta-analysis revealed that exposure to certain metalloestrogens, specifically arsenic (As), antimony (Sb), and copper (Cu), is associated with an increased risk of GDM. Arsenic exposure exhibited a risk ratio (OR = 1.28, 95% CI [1.08, 1.52]), antimony a higher risk (OR = 1.73, 95% CI [1.13, 2.65]), and copper was also linked with a modest increase in GDM risk (OR = 1.29, 95% CI [1.02, 1.63]). However, high heterogeneity in these studies was noted, with substantial variability in the results for arsenic (I2 = 64.1%), antimony (I2 = 80.9%), and copper (I2 = 71.6%). Other metalloestrogens, such as selenium, cadmium, chromium, and mercury, did not show a statistically significant association with GDM in this analysis.What Are the Greatest Implications of This Review?
The greatest implication of this review is the emerging recognition that environmental exposure to metalloestrogens could be a significant contributor to the risk of GDM. This finding underscores the importance of considering environmental and occupational exposure to harmful metals in pregnancy, which could lead to metabolic disturbances that increase the likelihood of GDM. The results suggest that public health policies should place greater emphasis on reducing environmental contamination by metalloestrogens, especially in populations at higher risk of GDM. Additionally, it points to the need for more targeted research on how different metals disrupt estrogenic pathways and influence insulin signaling and pancreatic function, which may open new avenues for preventive strategies, early diagnosis, and novel treatments for GDM. The high heterogeneity in the studies also highlights the complexity of the relationship between metalloestrogens and GDM. Variations in exposure levels, methods of measurement, and geographical factors call for standardized approaches in future research to better clarify these associations. Furthermore, the study suggests the necessity for increased awareness and education among healthcare providers regarding environmental factors in pregnancy, encouraging efforts to mitigate exposure in vulnerable populations.Lorem ipsum dolor sit amet, consectetur adipiscing elit. Proin ut laoreet tortor. Donec euismod fermentum pharetra. Nullam at tristique enim. In sit amet molestie
This study suggests that nickel sensitivity may play a significant role in the etiology of IBS, warranting further exploration and potentially influencing future diagnostic and therapeutic strategies for IBS management.
What was studied?
This study investigated the relationship between nickel (Ni) sensitivity and irritable bowel syndrome (IBS). Specifically, the researchers aimed to determine whether patients with IBS are more prone to nickel sensitivity than healthy individuals. The study utilized patch testing, a standard method for diagnosing contact allergies, to evaluate Ni sensitivity in both IBS patients and a healthy control group.
Who was studied?
The study included 50 patients diagnosed with IBS based on the Rome IV criteria and 40 healthy volunteers who served as the control group. Both groups were similar in terms of age, gender distribution, and dietary habits. The mean ages of the patient and control groups were 42.82 and 39.77 years, respectively, with no significant difference in age or gender between the groups. Exclusion criteria were applied to ensure that systemic medication, dietary restrictions, or recent use of nickel-containing products did not confound the results.
What were the most important findings?
Nickel sensitivity prevalence in IBS: The study found that 40% of the IBS patient group exhibited nickel sensitivity, compared to 17.5% of the control group. This difference was statistically significant (p=0.03), suggesting a strong association between Ni sensitivity and IBS.
Gender distribution: While nickel sensitivity was more common in women, with 45.8% of female IBS patients testing positive compared to 34.6% of male patients, the difference in sensitivity between genders was not statistically significant. However, among men, Ni sensitivity was significantly higher in the IBS group compared to the control group (p=0.03).
Nickel sensitivity’s role in IBS: The study supports the hypothesis that nickel sensitivity might play a role in the pathogenesis of IBS, corroborating earlier studies that suggested a link between nickel intake and gastrointestinal symptoms mimicking IBS.
What are the greatest implications of this study?
Clinical relevance of nickel sensitivity in IBS: This study highlights the potential role of dietary nickel in triggering or exacerbating IBS symptoms. If nickel sensitivity is confirmed as a contributor to IBS pathogenesis, dietary modifications such as low-nickel diets may be a viable treatment approach for some IBS patients, possibly improving symptoms and reducing treatment costs.
Future research directions: The findings suggest a need for more comprehensive studies to further explore the relationship between nickel sensitivity and IBS, as well as to investigate the pathophysiological mechanisms underlying this association. Additionally, larger studies could focus on whether low-nickel diets provide significant clinical improvement in IBS patients with nickel sensitivity.
Gender considerations in treatment: While nickel sensitivity is traditionally more associated with women, this study reveals that nickel sensitivity is significantly higher in men with IBS compared to healthy controls. This finding may influence future clinical approaches, encouraging practitioners to consider nickel sensitivity in both male and female IBS patients.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Proin ut laoreet tortor. Donec euismod fermentum pharetra. Nullam at tristique enim. In sit amet molestie
Did you know?
Gut microbiota predict endometriosis better than vaginal microbiota.
This study offers new insights into the potential link between nickel sensitivity and symptom severity in endometriosis, suggesting that a low-nickel diet may be a promising intervention for alleviating associated gastrointestinal and gynecological symptoms.
What Was Studied?
This pilot study investigated the prevalence of nickel (Ni) allergic contact mucositis (ACM) in women with endometriosis who experience gastrointestinal symptoms and evaluated the effects of a low-nickel diet on these symptoms. The study focused on assessing the gastrointestinal, extra-intestinal, and gynecological symptom reductions associated with Ni ACM and dietary interventions.
Who Was Studied?
The study enrolled 84 women of reproductive age diagnosed with endometriosis who reported significant gastrointestinal symptoms. Thirty-one participants completed the study, undergoing a diagnostic nickel oral mucosa patch test (omPT) and a subsequent three-month low-nickel diet intervention. Participants were evaluated using symptom questionnaires both at baseline and after dietary changes.
What Were the Most Important Findings?
The study found that 90.3% of participants tested positive for Ni ACM, suggesting a high prevalence of nickel sensitivity among women with endometriosis.Following three months of adhering to a low-nickel diet, significant reductions in all evaluated symptoms were reported. Gastrointestinal symptoms such as abdominal pain, bloating, and diarrhea showed marked improvement. Extra-intestinal symptoms, including fatigue and headaches, and gynecological symptoms such as pelvic pain and dysmenorrhea, also exhibited statistically significant decreases. These findings indicate that nickel sensitivity may contribute to the symptomatic burden of endometriosis, and dietary interventions targeting nickel can alleviate these issues.
The study suggests a potential mechanistic link between nickel exposure, immune responses, and the exacerbation of endometriosis symptoms. Major microbial associations (MMAs) relevant to this context include those influenced by dietary changes, although specific microbiome alterations were not detailed.
What Are the Greatest Implications of This Study?
This research highlights nickel sensitivity as a significant yet previously under-recognized contributor to gastrointestinal and systemic symptoms in endometriosis patients. The findings suggest that incorporating nickel sensitivity screening and low-nickel dietary recommendations could represent a transformative approach to symptom management in endometriosis. Although the sample size was small, the results offer strong preliminary evidence for revising dietary protocols in clinical practice to include low-nickel guidelines, potentially improving the quality of life for patients.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Proin ut laoreet tortor. Donec euismod fermentum pharetra. Nullam at tristique enim. In sit amet molestie
This review opens new avenues in toxicology and endocrine research, identifying metalloestrogens as a critical factor in hormone disruption and breast cancer risk. Further studies are necessary to confirm these findings and develop effective mitigation strategies for human health protection.
What was reviewed?
This study, published in the Journal of Applied Toxicology, reviewed the concept and emerging evidence of metalloestrogens mimicking estrogenic activity. The review focused on how these metals interact with estrogen receptors (ERs) like organic xenoestrogens, potentially contributing to estrogenic activity in human breast tissue and increasing the risk of hormone-related cancers such as breast cancer. The review primarily covered in vitro and in vivo studies of various metal ions, including aluminum, antimony, arsenite, barium, cadmium, chromium (Cr(II)), cobalt, copper, lead, mercury, nickel, selenite, tin, and vanadate. The review also highlights significant research contributions from multiple studies and scholars focusing on the effects of metalloestrogens on human breast cancer cell lines, such as MCF-7 and T47D, as well as their impact on gene expression and cellular proliferation.
Most Important Findings:
Estrogenic Activity of Metals: The review found that various metal ions can act as estrogen agonists by binding to estrogen receptors, particularly ERα, and mimicking the actions of physiological estrogens. This was demonstrated in studies showing that metals such as cadmium, nickel, and aluminum could displace estradiol from the ligand-binding domain of ERα, leading to altered gene expression and increased cell proliferation in breast cancer cells.
Molecular Mechanisms: Metals such as cadmium were shown to bind directly to the ligand-binding domain (LBD) of the estrogen receptor, interfering with the receptor's normal function. This binding alters the receptor’s ability to interact with estrogen response elements (EREs) on DNA, thereby affecting the transcription of estrogen-regulated genes. For instance, cadmium was found to downregulate ER levels and upregulate estrogen-regulated gene expression, driving cell proliferation.
Cooperative Action with Estrogens: The metals did not antagonize estradiol’s action; instead, they often enhanced the agonist actions of estradiol. In some cases, metals like copper and cobalt increased breast cancer cell proliferation when combined with estradiol, indicating a synergistic effect that may exacerbate estrogenic signaling in hormone-dependent cancers.
In Vivo Evidence: The review highlighted evidence of in vivo estrogenic activity in animal models, particularly for cadmium, which was shown to increase uterine weight, induce mammary gland development, and alter gene expression. The estrogenic effects of cadmium were noted at doses relevant to human exposure, raising significant concerns about environmental exposure to these metals.
Environmental and Occupational Exposure: The presence of metalloestrogens such as cadmium and aluminum in everyday consumer products (e.g., antiperspirants) and the environment (e.g., tobacco smoke, and industrial pollutants) implies widespread human exposure. These metals can accumulate in the body, especially in breast tissue, and may contribute to the burden of aberrant estrogen signaling involved in breast cancer development.
Greatest Implications:
Breast Cancer Risk: The review underscores the potential for metalloestrogens to increase the risk of breast cancer by contributing to estrogenic signaling within breast tissue. Given that breast cancer is often driven by estrogen receptor activation, the cumulative burden of environmental estrogens and metalloestrogens could enhance the likelihood of cancer development and progression.
Environmental Health and Toxicology: The widespread presence of these metals in the environment, their ability to accumulate in the body, and their newly recognized estrogenic activity suggest a need for revised regulatory guidelines and risk assessments for human exposure to metalloestrogens. This includes re-evaluating safe exposure levels, especially for metals like cadmium, which is already classified as a human carcinogen.
Endocrine Disruption: The concept of metalloestrogens extends the traditional understanding of endocrine-disrupting chemicals (EDCs) beyond organic compounds, emphasizing the need for further investigation into how inorganic metals may impact hormone-related diseases. This review calls for more research on the long-term effects of chronic exposure to metalloestrogens in both wildlife and humans.
Public Health Awareness: There is a strong implication for public health education regarding the sources of metalloestrogen exposure, such as antiperspirants, diet, cigarette smoke, and industrial pollutants. Raising awareness could lead to better personal care practices and lifestyle choices to reduce individual exposure to these potentially harmful metal ions.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Proin ut laoreet tortor. Donec euismod fermentum pharetra. Nullam at tristique enim. In sit amet molestie
This study examined the presence of metalloestrogens in ectopic endometrial tissue from fifty women diagnosed with endometriosis. Cadmium, nickel, and lead were found in all tissue samples, with nickel and lead showing particularly high concentrations. These findings suggest that metalloestrogens play a role in the etiology of endometriosis by interacting with estrogen receptors, emphasizing environmental pollutants' role in endometriosis progression.
What was studied?
This study investigated the presence of metalloestrogens in ectopic endometrial tissue from women with endometriosis. Metalloestrogens, heavy metals that can mimic estrogen and may contribute to estrogen-dependent diseases, were the focus, particularly regarding their potential role in the persistence and pathology of endometriosis. The researchers specifically analyzed levels of cadmium, nickel, and lead in ectopic endometrial samples using advanced metal detection techniques, Total Reflection X-ray Fluorescence (TXRF) and Graphite Furnace Atomic Absorption Spectroscopy (GFASS).
Who was studied?
The study included fifty women of reproductive age diagnosed with endometriosis via laparoscopy or laparotomy at the Professorial Gynecology Unit of the National Hospital, Colombo, Sri Lanka, during 2009-2010. The participants underwent these procedures for diagnosis or treatment, and endometriotic tissue samples were collected during surgery. The participants presented with varied symptoms like infertility, dysmenorrhea, chronic pelvic pain, and endometriomas.
What were the most important findings?
The study found significant levels of cadmium, nickel, and lead in all ectopic endometrial tissue samples. Specifically, geometric mean concentrations were reported as follows: cadmium (2.861 μg/Kg), nickel (17.547 μg/Kg), and lead (25.785 μg/Kg). The concentrations varied by tissue site, with the ovarian endometrioma wall showing higher, though not statistically significant, metal levels than pelvic endometrial patches or nodules in the pouch of Douglas.
Implications
This study is one of the first to identify and quantify metalloestrogens in ectopic endometrial tissue, shedding light on a possible environmental and molecular link to endometriosis. It underscores the mechanism by which these metals could perpetuate endometriosis, given their ability to interact with estrogen receptors in ectopic tissue. The implications are substantial for public health, especially given the widespread environmental exposure to metals such as cadmium, nickel, and lead. These findings suggest that environmental pollution may play a significant role in the etiology and progression of endometriosis, calling for further investigation into the estrogen-mimicking properties of environmental metals and their regulation. Additionally, the study highlights the need for preventive measures to reduce heavy metal exposure to nickel and lead, particularly among women susceptible to estrogen-related diseases.
Endometriosis involves ectopic endometrial tissue causing pain and infertility. Validated and Promising Interventions include Hyperbaric Oxygen Therapy (HBOT), Low Nickel Diet, and Metronidazole therapy.
Bacteria regulate transition metal levels through complex mechanisms to ensure survival and adaptability, influencing both their physiology and the development of antimicrobial strategies.
Metalloestrogens are metals that activate the estrogen receptor in the absence of estradiol.
β-glucuronidase in the gut microbiome breaks down metabolites, drugs, and hormone conjugates like estrogen, aiding microbial energy use and nutrient cycling. Its activity influences drug efficacy and hormone levels, maintaining estrogen balance and impacting health. Disruption in this process can lead to estrogen-related diseases, such as gynecological cancers and menopausal syndrome, and increase colorectal cancer risks by reactivating carcinogens, highlighting its pivotal role in linking microbial actions to host physiological processes.
Endometriosis involves ectopic endometrial tissue causing pain and infertility. Validated and Promising Interventions include Hyperbaric Oxygen Therapy (HBOT), Low Nickel Diet, and Metronidazole therapy.
Clinoptilolite zeolite binds nickel ions, reducing pathogen activity, making it a potential therapy for nickel allergies and nickel-induced microbiome imbalances.
Bacteria regulate transition metal levels through complex mechanisms to ensure survival and adaptability, influencing both their physiology and the development of antimicrobial strategies.
Endometriosis involves ectopic endometrial tissue causing pain and infertility. Validated and Promising Interventions include Hyperbaric Oxygen Therapy (HBOT), Low Nickel Diet, and Metronidazole therapy.
Irritable Bowel Syndrome (IBS) is a common gastrointestinal disorder characterized by symptoms such as abdominal pain, bloating, and altered bowel habits. Recent research has focused on the gut microbiota's role in IBS, aiming to identify specific microbial signatures associated with the condition.
A low-nickel diet (LNiD) is a therapeutic dietary intervention that eliminates high-nickel foods, primarily plant-based sources such as legumes, nuts, whole grains, and cocoa, to reduce systemic nickel exposure. It is clinically validated for managing systemic nickel allergy syndrome (SNAS) and nickel-induced eczema. Its relevance is well-established in microbiome modulation, with studies demonstrating clinical benefits in conditions such as endometriosis, fibromyalgia, irritable bowel syndrome, and GERD.
Endometriosis involves ectopic endometrial tissue causing pain and infertility. Validated and Promising Interventions include Hyperbaric Oxygen Therapy (HBOT), Low Nickel Diet, and Metronidazole therapy.
Infertility is the inability to conceive after 12 months of regular, unprotected sex. It affects both men and women and can be due to various physical, hormonal, or genetic factors. Treatments include medication, surgery, assisted reproductive technologies, and lifestyle changes.
References
- Metal-dependent hormone function: the emerging interdisciplinary field of metalloendocrinology.. Stevenson MJ, Uyeda KS, Harder NHO, Heffern MC.. (Metallomics. 2019)
- Presence of metalloestrogens in ectopic endometrial tissue.. Silva, N. & Senanayake, Hemantha & Peiris-John, Roshini & Wickremasinghe, Rajitha & Sathiakumar, Nalini & Waduge, Vajira. (J Pharm Biomed Sci. (2012))
Stevenson MJ, Uyeda KS, Harder NHO, Heffern MC.
Metal-dependent hormone function: the emerging interdisciplinary field of metalloendocrinology.Metallomics. 2019
Silva, N. & Senanayake, Hemantha & Peiris-John, Roshini & Wickremasinghe, Rajitha & Sathiakumar, Nalini & Waduge, Vajira
Presence of metalloestrogens in ectopic endometrial tissue.J Pharm Biomed Sci. (2012)